Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics Inks Deal with MultiPlan for Access to Tests, Services

NEW YORK (GenomeWeb News) – Cancer Genetics today announced an agreement with MultiPlan, allowing healthcare providers in MultiPlan's network to offer Cancer Genetics' tests and testing services to their patients.

According to MultiPlan, it has contracts with about 800,000 providers in the US, providing access to its network products to about 57 million consumers. On Monday, Genetic Technologies announced a similar agreement with the New York-based managed-care firm for its BrevaGen breast cancer test.

"This is a tremendous opportunity for us and further validates our position in cancer diagnostics," Panna Sharma, president and CEO of Cancer Genetics, said in a statement. "We expect the MultiPlan agreement to increase access to our oncology-focused services for patients and clinicians while also improving our reimbursement rate and reducing our [days sales outstanding]."

Financial and other terms of the deal were not disclosed.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.